Daiichi Sankyo's net income FY 2013-2022
In the fiscal year 2022, Daiichi Sankyo's profit amounted to approximately 109 billion Japanese yen. Figures peaked in fiscal 2014, reaching around 322.1 billion Japanese yen. The main products of the Japanese pharmaceutical company include oncology medications, cardiovascular medications, and vaccines.